Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Yaseen Arabi and Frederick Hayden.
Yaseen Arabi
Connection Strength
3.382
Frederick Hayden
  1. Critical care management of adults with community-acquired severe respiratory viral infection. Intensive Care Med. 2020 02; 46(2):315-328.
    View in: PubMed
    Score: 0.866
  2. Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome. N Engl J Med. 2020 10 22; 383(17):1645-1656.
    View in: PubMed
    Score: 0.227
  3. Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study. Clin Infect Dis. 2020 04 15; 70(9):1837-1844.
    View in: PubMed
    Score: 0.219
  4. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-ß1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. Trials. 2020 Jan 03; 21(1):8.
    View in: PubMed
    Score: 0.215
  5. Macrolides in critically ill patients with Middle East Respiratory Syndrome. Int J Infect Dis. 2019 Apr; 81:184-190.
    View in: PubMed
    Score: 0.201
  6. Critically ill healthcare workers with the middle east respiratory syndrome (MERS): A multicenter study. PLoS One. 2018; 13(11):e0206831.
    View in: PubMed
    Score: 0.199
  7. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome. Am J Respir Crit Care Med. 2018 03 15; 197(6):757-767.
    View in: PubMed
    Score: 0.190
  8. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-ß1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials. 2018 Jan 30; 19(1):81.
    View in: PubMed
    Score: 0.188
  9. Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study. Crit Care Med. 2017 10; 45(10):1683-1695.
    View in: PubMed
    Score: 0.184
  10. Middle East Respiratory Syndrome. N Engl J Med. 2017 02 09; 376(6):584-594.
    View in: PubMed
    Score: 0.176
  11. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. Emerg Infect Dis. 2016 09; 22(9):1554-61.
    View in: PubMed
    Score: 0.171
  12. The search for therapeutic options for Middle East Respiratory Syndrome (MERS). J Infect Public Health. 2016 May-Jun; 9(3):213-5.
    View in: PubMed
    Score: 0.166
  13. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus. 2015; 4:709.
    View in: PubMed
    Score: 0.162
  14. Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update. Crit Care Med. 2021 03 01; 49(3):e219-e234.
    View in: PubMed
    Score: 0.058
  15. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. 2020 06; 48(6):e440-e469.
    View in: PubMed
    Score: 0.055
  16. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 05; 46(5):854-887.
    View in: PubMed
    Score: 0.055
  17. Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome. Influenza Other Respir Viruses. 2019 07; 13(4):382-390.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.